Gilead Creating Possible
🌐 English (EN)
  • English (EN)
  • äø­ę–‡(繁體)
Contact Us
Gilead Logo
EN
  • English (EN)
  • äø­ę–‡(繁體)
  • Our Purpose
    Mission and Core Values Partnerships and Community Sustainability Advancing Global Health Corporate Giving
  • About
    General Manager’s Message Gilead in Asia
  • Science and Medicine
    Our Therapeutic Areas Medicines Take Charge of Your Health
  • News and Press
    Newsroom
  • Careers
    Careers
  • Utility
    Terms of Use Sitemap
BACK TO MAIN MENU Partnerships and Community Creating a Healthier Asia Video Series Elevating the Voices of People Living with Hepatitis B
  • Contact Us
Toggle Inner Dropdown
BACK TO MAIN MENU Google.com
  • Newsroom

Newsroom

Press Releases

28 November 2022

Strong Demand for Telehealth Services Among People Living with HIV In Hong Kong, Dedicated Mobile App Fills Gap for Much-Needed Patient Care Support

19 April 2022

Gilead Sciences and National Foundation of Digestive Disease Set Out to Strengthen Learning, Access to Liver Health Education in Singapore

29 November 2021

Gilead Sciences Awards Over $1.5 Million USD in Grants Supporting Communities to Help End the HIV Epidemic in Asia Pacific

23 November 2021

Gilead Sciences, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), and the World Hepatitis Alliance (WHA) Collaborate to Support Elimination of Hepatitis by 2030

13 October 2021

Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America

28 July 2021

Gilead Sciences Announces Launch of Asia Pacific ALL4LIVER Grant 2021

29 March 2021

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2021

30 November 2020

Gilead Sciences’ Pulse Survey Highlights Majority of People Living with HIV, Individuals at Risk and HIV Care Prescribers in Asia Pacific Experience Disruptions in HIV Care During Covid-19 Pandemic

6 July 2020

Gilead Commits US$500,000 in Financial and Resource Support to Communities in Need in Singapore, Hong Kong, South Korea and Taiwan

This website is intended for residents of Hong Kong and Macau.
Ā© 2022 Gilead Sciences, Inc. All rights reserved.

INFORMATION

  • Contact Us
  • Sitemap

DISCLOSURES

  • Cookie Statement
  • Privacy Statement
  • Terms of Use
Interstitial

You are now leaving www.gilead.com.hk and visiting a third-party website which is not owned or controlled by Gilead Sciences. Links to these sites are provided as a resource to our visitors. Gilead does not assume responsibility for any content on linked sites.

Ok Cancel